Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Addressing nanomaterial immunosafety by evaluating innate immunity across living species

  • Boraschi, Diana
  • Alijagic, Andi
  • Auguste, Manon
  • Barbero, Francesco
  • Ferrari, Eleonora
  • Hernadi, Szabolcs
  • Mayall, Craig
  • Michelini, Sara
  • Navarro Pacheco, Natividad I.
  • Prinelli, Alessandra
  • Swart, Elmer
  • Swartzwelter, Benjamin J.
  • Bastús, Neus G.
  • Canesi, Laura
  • Drobne, Damjana
  • Duschl, Albert
  • Ewart, Marie-Ann
  • Horejs-Hoeck, Jutta
  • Italiani, Paola
  • Kemmerling, Birgit
  • Kille, Peter
  • Prochazkova, Petra
  • Puntes, Víctor F.
  • Spurgeon, David J.
  • Svendsen, Claus
  • Wilde, Colin J.
  • Pinsino, Annalisa
The interaction of a living organism with external foreign agents is a central issue for its survival and adaptation to the environment. Nanosafety should be considered within this perspective, and it should be examined that how different organisms interact with engineered nanomaterials (NM) by either mounting a defensive response or by physiologically adapting to them. Herein, the interaction of NM with one of the major biological systems deputed to recognition of and response to foreign challenges, i.e., the immune system, is specifically addressed. The main focus is innate immunity, the only type of immunity in plants, invertebrates, and lower vertebrates, and that coexists with adaptive immunity in higher vertebrates. Because of their presence in the majority of eukaryotic living organisms, innate immune responses can be viewed in a comparative context. In the majority of cases, the interaction of NM with living organisms results in innate immune reactions that eliminate the possible danger with mechanisms that do not lead to damage. While in some cases such interaction may lead to pathological consequences, in some other cases beneficial effects can be identified., All authors were supported by the EU H2020 project PANDORA (GA 671881). The authors gratefully acknowledge the following additional financial support: EU H2020 project ENDONANO (GA 812661; PI, AD, VFP); the Italian Ministry of Research Flagship project InterOmics (DB, PI); the Austrian FWF Doctoral Program W1213: Immunity in Cancer and Allergy (ICA; AD, JHH); Catalan Agència de Gestió d'Ajuts Universitaris i de Recerca (2017‐SGR‐1431; VFP, NGB), Ramon y Cajal program (RYC‐2012‐10991; NGB); Severo Ochoa program from Spanish MINECO (Grant No. SEV‐2017‐0706; VFP, NGB); CERCA Programme/Generalitat de Catalunya (NGB). Supported by the project LO1509 of the Ministry of Education, Youth and Sports (Czech Republic) for providing the electron microscopy images., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Innate Memory Reprogramming by Gold Nanoparticles Depends on the Microbial Agents That Induce Memory

  • Swartzwelter, Benjamin J.
  • Michelini, Sara
  • Frauenlob, Tobias
  • Barbero, Francesco
  • Verde, Alessandro
  • Chiara de Luca, Anna
  • Puntes, Víctor F.
  • Duschl, Albert
  • Horejs-Hoeck, Jutta
  • Italiani, Paola
  • Boraschi, Diana
Innate immune memory, the ability of innate cells to react in a more protective way to secondary challenges, is induced by exposure to infectious and other exogeous and endogenous agents. Engineered nanoparticles are particulate exogenous agents that, as such, could trigger an inflammatory reaction in monocytes and macrophages and could therefore be also able to induce innate memory. Here, we have evaluated the capacity of engineered gold nanoparticles (AuNPs) to induce a memory response or to modulate the memory responses induced by microbial agents. Microbial agents used were in soluble vs. particulate form (MDP and the gram-positive bacteria Staphylococcus aureus; β-glucan and the β-glucan-producing fungi C. albicans), and as whole microrganisms that were either killed (S. aureus, C. albicans) or viable (the gram-negative bacteria Helicobacter pylori). The memory response was assessed in vitro, by exposing human primary monocytes from 2-7 individual donors to microbial agents with or without AuNPs (primary response), then resting them for 6 days to allow return to baseline, and eventually challenging them with LPS (secondary memory response). Primary and memory responses were tested as production of the innate/inflammatory cytokine TNFα and other inflammatory and anti-inflammatory factors. While inactive on the response induced by soluble microbial stimuli (muramyl dipeptide -MDP-, β-glucan), AuNPs partially reduced the primary response induced by whole microorganisms. AuNPs were also unable to directly induce a memory response but could modulate stimulus-induced memory in a circumscribed fashion, limited to some agents and some cytokines. Thus, the MDP-induced tolerance in terms of TNFα production was further exacerbated by co-priming with AuNPs, resulting in a less inflammatory memory response. Conversely, the H. pylori-induced tolerance was downregulated by AuNPs only relative to the anti-inflammatory cytokine IL-10, which would lead to an overall more inflammatory memory response. These effects of AuNPs may depend on a differential interaction/association between the reactive particle surfaces and the microbial components and agents, which may lead to a change in the exposure profiles. As a general observation, however, the donor-to-donor variability in memory response profiles and reactivity to AuNPs was substantial, suggesting that innate memory depends on the individual history of exposures., This work was supported by the EU Commission H2020 projects PANDORA (GA 671881) and ENDONANO (GA 812661), the Italian MIUR InterOmics Flagship projects MEMORAT and MAME, the Italian MIUR/PRIN-20173ZECCM, the Priority program ACBN (Allergy Cancer BioNano Research Centre) of the University of Salzburg, the Cancer Cluster Salzburg, the Research Grant from the University of Salzburg, and the Austrian Science Fund (FWF) Grant Nr. P 29941.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding

  • Magnani, Maria
  • Verde, Alessandro
  • Boraschi, Diana
  • Puntes, Víctor F.
  • Italiani, Paola
  • Chiara de Luca, Anna
The interaction between engineered nanoparticles and the bacterial lipopolysaccharide, or endotoxin, is an event that warrants attention. Endotoxin is one of the most potent stimulators of inflammation and immune reactions in human beings, and is a very common contaminant in research labs. In nanotoxicology and nanomedicine, the presence of endotoxin on the nanoparticle surface affects their biological properties leading to misinterpretation of results. This review discusses the importance of detecting the endotoxin contamination on nanoparticles, focusing on the current method of endotoxin detection and their suitability for nanoparticulate materials. Conversely, the capacity of nanoparticles to bind endotoxin can be enhanced by functionalization with endotoxin-capturing molecules, opening the way to the development of novel endotoxin detection assays., The authors were supported by the EU H2020 grants ENDONANO [GA 812661] and PANDORA [GA 671881], the IG grant [21420] of the Associazione Italiana Ricerca sul Cancro (AIRC), the project NeON [ARS01_00769] of the Program PRIN, and the projects CIRO- Campania Infrastructure for Research in Oncology and PLATT of the Programma Operativo Regionale of Regione Campania [POR FERS 2014/2020].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The interactions between nanoparticles and the innate immune system from a nanotechnologist perspective

  • Ernst, Lena M.
  • Casals, Eudald
  • Italiani, Paola
  • Boraschi, Diana
  • Puntes, Víctor F.
The immune system contributes to maintaining the body’s functional integrity through its two main functions: recognizing and destroying foreign external agents (invading microorganisms) and identifying and eliminating senescent cells and damaged or abnormal endogenous entities (such as cellular debris or misfolded/degraded proteins). Accordingly, the immune system can detect molecular and cellular structures with a spatial resolution of a few nm, which allows for detecting molecular patterns expressed in a great variety of pathogens, including viral and bacterial proteins and bacterial nucleic acid sequences. Such patterns are also expressed in abnormal cells. In this context, it is expected that nanostructured materials in the size range of proteins, protein aggregates, and viruses with different molecular coatings can engage in a sophisticated interaction with the immune system. Nanoparticles can be recognized or passed undetected by the immune system. Once detected, they can be tolerated or induce defensive (inflammatory) or anti-inflammatory responses. This paper describes the different modes of interaction between nanoparticles, especially inorganic nanoparticles, and the immune system, especially the innate immune system. This perspective should help to propose a set of selection rules for nanosafety-by-design and medical nanoparticle design., This research was funded by the EU Commission H2020 project PANDORA (GA 671881; to D.B., P.I. and V.P.). Additional funds were provided by the EU Commission H2020 project ENDONANO (GA 812661; to P.I. and D.B.), the Italian MIUR InterOmics Flagship projects MEMORAT and MAME (to D.B. and P.I.), the Italian MIUR/PRIN-20173ZECCM (to P.I.), the CAS President’s International Fellowship Programme (PIFI; award 2020VBA0028; to D.B.), Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) (RTI2018-099965-B-I00, AEI/FEDER, UE), and Generalitat de Catalunya (2017-SGR-1431) (V.P.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Induction of Innate Memory in Human Monocytes Exposed to Mixtures of Bacterial Agents and Nanoparticles

  • Della Camera, Giacomo
  • Liu, Tinghao
  • Yang, Wenjie
  • Li, Yang
  • Puntes, Víctor F.
  • Gioria, Sabrina
  • Italiani, Paola
  • Boraschi, Diana
We assessed whether concomitant exposure of human monocytes to bacterial agents and different engineered nanoparticles can affect the induction of protective innate memory, an immune mechanism that affords better resistance to diverse threatening challenges. Monocytes were exposed in vitro to nanoparticles of different chemical nature, shape and size either alone or admixed with LPS, and cell activation was assessed in terms of production of inflammatory (TNFα, IL-6) and anti-inflammatory cytokines (IL-10, IL-1Ra). After return to baseline conditions, cells were re-challenged with LPS and their secondary “memory” response measured. Results show that nanoparticles alone are essentially unable to generate memory, while LPS induced a tolerance memory response (less inflammatory cytokines, equal or increased anti-inflammatory cytokines). LPS-induced tolerance was not significantly affected by the presence of nanoparticles during the memory generation phase, although with substantial donor-to-donor variability. This suggests that, despite the overall lack of significant effects on LPS-induced innate memory, nanoparticles may have donor-specific effects. Thus, future nanosafety assessment and nanotherapeutic strategies will need a personalized approach in order to ensure both the safety and efficacy of nano medical compounds for individual patients., This work was supported by the EU Commission H2020 projects PANDORA (GA671881) and ENDONANO (GA 812661) (PI, DB), the Italian MIUR InterOmics Flagship projects MEMORAT and MAME (DB, PI), and the Presidential International Fellowship Program (PIFI) of the Chinese Academy of Science (2020VBA0028) (DB). Part of this work was carried out in the context of the JRC Visiting Scientist agreement no. 05/JRC.F.2/2019 (Directorate F—Health, Consumers and Reference Materials, Consumer Products Safety, Nanobiotechnology Lab).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recovering what matters: High protein recovery after endotoxin removal from LPS-contaminated formulations using novel anti-lipid a antibody microparticle conjugates

  • Casonato Melo, Cristiane
  • Fux, Alexandra C.
  • Himly, Martin
  • Bastús, Neus G.
  • Schlahsa, Laura
  • Siewert, Christiane
  • Puntes, Víctor F.
  • Duschl, Albert
  • Gessner, Isabel
  • Fauerbach, Jonathan A.
Endotoxins or lipopolysaccharides (LPS), found in the outer membrane of Gram-negative bacterial cell walls, can stimulate the human innate immune system, leading to life-threatening symptoms. Therefore, regulatory limits for endotoxin content apply to injectable pharmaceuticals, and excess LPS must be removed before commercialization. The majority of available endotoxin removal systems are based on the non-specific adsorption of LPS to charged and/or hydrophobic surfaces. Albeit effective to remove endotoxins, the lack of specificity can result in the unwanted loss of essential proteins from the pharmaceutical formulation. In this work, we developed microparticles conjugated to anti-Lipid A antibodies for selective endotoxin removal. Anti-Lipid A particles were characterized using flow cytometry and microscopy techniques. These particles exhibited a depletion capacity > 6 ×103 endotoxin units/mg particles from water, as determined with two independent methods (Limulus Amebocyte Lysate test and nanoparticle tracking analysis). Additionally, we compared these particles with a non-specific endotoxin removal system in a series of formulations of increasing complexity: bovine serum albumin in water < insulin in buffer < birch pollen extracts. We demonstrated that the specific anti-Lipid A particles show a higher protein recovery without compromising their endotoxin removal capacity. Consequently, we believe that the specificity layer integrated by the anti-Lipid A antibody could be advantageous to enhance product yield., The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 812661, H2020-MSCA-ITN-2018-812661 (ENDONANO)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates

  • Casonato Melo, Cristiane
  • Fux, Alexandra
  • Himly, Martin
  • Schlahsa, Laura
  • Siewert, Christiane
  • Franco Puntes, Victor
  • G. Bastús, Neus
Bioconjugation; Polystyrene particles; Supramolecular structures, Bioconjugación; Partículas de poliestireno; Estructuras supramoleculares, Bioconjugació; Partícules de poliestirè; Estructures supramoleculars, Endotoxins or lipopolysaccharides (LPS), found in the outer membrane of Gram-negative bacterial cell walls, can stimulate the human innate immune system, leading to life-threatening symptoms. Therefore, regulatory limits for endotoxin content apply to injectable pharmaceuticals, and excess LPS must be removed before commercialization. The majority of available endotoxin removal systems are based on the non-specific adsorption of LPS to charged and/or hydrophobic surfaces. Albeit effective to remove endotoxins, the lack of specificity can result in the unwanted loss of essential proteins from the pharmaceutical formulation. In this work, we developed microparticles conjugated to anti-Lipid A antibodies for selective endotoxin removal. Anti-Lipid A particles were characterized using flow cytometry and microscopy techniques. These particles exhibited a depletion capacity > 6 ×103 endotoxin units/mg particles from water, as determined with two independent methods (Limulus Amebocyte Lysate test and nanoparticle tracking analysis). Additionally, we compared these particles with a non-specific endotoxin removal system in a series of formulations of increasing complexity: bovine serum albumin in water < insulin in buffer < birch pollen extracts. We demonstrated that the specific anti-Lipid A particles show a higher protein recovery without compromising their endotoxin removal capacity. Consequently, we believe that the specificity layer integrated by the anti-Lipid A antibody could be advantageous to enhance product yield., The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 812661, H2020-MSCA-ITN-2018-812661 (ENDONANO).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interaction between macrophages and nanoparticles, in vitro 3d cultures for the realistic assessment of inflammatory activation and modulation of innate memory

  • Swartzwelter, Benjamin|||0000-0002-6283-5199
  • Verde, Alessandro
  • Rehak, Laura
  • Madej, Mariusz
  • Puntes, Víctor|||0000-0001-8996-9499
  • De Luca, Anna Chiara|||0000-0002-3696-8465
  • Boraschi, Diana|||0000-0002-3953-4056
  • Italiani, Paola|||0000-0001-9830-2733
Understanding the modes of interaction between human monocytes/macrophages and engineered nanoparticles is the basis for assessing particle safety, in terms of activation of innate/inflammatory reactions, and their possible exploitation for medical applications. In vitro assessment of nanoparticle-macrophage interaction allows for examining the response of primary human cells, but the conventional 2D cultures do not reproduce the three-dimensional spacing of a tissue and the interaction of macrophages with the extracellular tissue matrix, conditions that shape macrophage recognition capacity and reactivity. Here, we have compared traditional 2D cultures with cultures on a 3D collagen matrix for evaluating the capacity gold nanoparticles to induce monocyte activation and subsequent innate memory in human blood monocytes in comparison to bacterial LPS. Results show that monocytes react to stimuli almost in the same way in 2D and 3D cultures in terms of production of TNFα and IL-6, but that notable differences are found when IL-8 and IL-1Ra are examined, in particular in the recall/memory response of primed cells to a second stimulation, with the 3D cultures showing cell activation and memory effects of nanoparticles better. In addition, the response variations in monocytes/macrophages from different donors point towards a personalized assessment of the nanoparticle effects on macrophage activation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gold Nanoparticles Modulate BCG-Induced Innate Immune Memory in Human Monocytes by Shifting the Memory Response towards Tolerance

  • Swartzwelter, Benjamin J.
  • Barbero, Francesco|||0000-0001-8704-0651
  • Verde, Alessandro
  • Mangini, Maria
  • Pirozzi, Marinella
  • De Luca, Anna Chiara|||0000-0002-3696-8465
  • Puntes, Víctor|||0000-0001-8996-9499
  • Leite, Luciana C. C.
  • Italiani, Paola|||0000-0001-9830-2733
  • Boraschi, Diana|||0000-0002-3953-4056
Innate immune memory is characterized by a modulation in the magnitude with which innate immune cells such as monocytes and macrophages respond to potential dangers, subsequent to previous exposure to the same or unrelated agents. In this study, we have examined the capacity of gold nanoparticles (AuNP), which are already in use for therapeutic and diagnostic purposes, to modulate the innate memory induced by bacterial agents. The induction of innate memory was achieved in vitro by exposing human primary monocytes to bacterial agents (lipopolysaccharide -LPS-, or live Bacille Calmette-Guérin -BCG) in the absence or presence of AuNP. After the primary activation, cells were allowed to return to a resting condition, and eventually re-challenged with LPS. The induction of memory was assessed by comparing the response to the LPS challenge of unprimed cells with that of cells primed with bacterial agents and AuNP. The response to LPS was measured as the production of inflammatory (TNFα, IL-6) and anti-inflammatory cytokines (IL-10, IL-1Ra). While ineffective in directly inducing innate memory per se, and unable to influence LPS-induced tolerance memory, AuNP significantly affected the memory response of BCG-primed cells, by inhibiting the secondary response in terms of both inflammatory and anti-inflammatory factor production. The reprogramming of BCG-induced memory towards a tolerance type of reactivity may open promising perspectives for the use of AuNP in immunomodulatory approaches to autoimmune and chronic inflammatory diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Addressing nanomaterial immunosafety by evaluating innate immunity across living species

  • Boraschi, Diana|||0000-0002-3953-4056
  • Alijagic, Andi|||0000-0002-2403-7989
  • Auguste, Manon|||0000-0002-3219-7931
  • Barbero, Francesco|||0000-0001-8704-0651
  • Ferrari, Eleonora
  • Hernadi, Szabolcs
  • Mayall, Craig|||0000-0002-1345-308X
  • Michelini, Sara|||0000-0001-9470-3337
  • Navarro Pacheco, Natividad Isabel|||0000-0001-9064-0666
  • Prinelli, Alessandra
  • Swart, Elmer|||0000-0002-8269-1700
  • Swartzwelter, Benjamin|||0000-0002-6283-5199
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Canesi, Laura|||0000-0003-2061-3819
  • Drobne, Damjana|||0000-0002-5970-7460
  • Duschl, Albert|||0000-0002-7034-9860
  • Ewart, Marie-Ann
  • Horejs-Hoeck, Jutta|||0000-0002-0984-204X
  • Italiani, Paola|||0000-0001-9830-2733
  • Kemmerling, Birgit
  • Kille, Peter
  • Prochazkova, Petra
  • Puntes, Víctor|||0000-0001-8996-9499
  • Spurgeon, David J.|||0000-0003-3264-8760
  • Svendsen, Claus
  • Wilde, Colin J.|||0000-0002-6872-0245
  • Pinsino, Annalisa|||0000-0002-0021-3909
The interaction of a living organism with external foreign agents is a central issue for its survival and adaptation to the environment. Nanosafety should be considered within this perspective, and it should be examined that how different organisms interact with engineered nanomaterials (NM) by either mounting a defensive response or by physiologically adapting to them. Herein, the interaction of NM with one of the major biological systems deputed to recognition of and response to foreign challenges, i.e., the immune system, is specifically addressed. The main focus is innate immunity, the only type of immunity in plants, invertebrates, and lower vertebrates, and that coexists with adaptive immunity in higher vertebrates. Because of their presence in the majority of eukaryotic living organisms, innate immune responses can be viewed in a comparative context. In the majority of cases, the interaction of NM with living organisms results in innate immune reactions that eliminate the possible danger with mechanisms that do not lead to damage. While in some cases such interaction may lead to pathological consequences, in some other cases beneficial effects can be identified.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The interactions between nanoparticles and the innate immune system from a nanotechnologist perspective

  • Ernst, Lena M.|||0000-0002-5713-7513
  • Casals, Eudald|||0000-0002-2900-7295
  • Italiani, Paola|||0000-0001-9830-2733
  • Boraschi, Diana|||0000-0002-3953-4056
  • Puntes, Víctor|||0000-0001-8996-9499
The immune system contributes to maintaining the body's functional integrity through its two main functions: recognizing and destroying foreign external agents (invading microorganisms) and identifying and eliminating senescent cells and damaged or abnormal endogenous entities (such as cellular debris or misfolded/degraded proteins). Accordingly, the immune system can detect molecular and cellular structures with a spatial resolution of a few nm, which allows for detecting molecular patterns expressed in a great variety of pathogens, including viral and bacterial proteins and bacterial nucleic acid sequences. Such patterns are also expressed in abnormal cells. In this context, it is expected that nanostructured materials in the size range of proteins, protein aggregates, and viruses with different molecular coatings can engage in a sophisticated interaction with the immune system. Nanoparticles can be recognized or passed undetected by the immune system. Once detected, they can be tolerated or induce defensive (inflammatory) or anti-inflammatory responses. This paper describes the different modes of interaction between nanoparticles, especially inorganic nanoparticles, and the immune system, especially the innate immune system. This perspective should help to propose a set of selection rules for nanosafety-by-design and medical nanoparticle design.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding

  • Mangini, MARIA|||0000-0002-4524-6317
  • Verde, Alessandro
  • Boraschi, Diana|||0000-0002-3953-4056
  • Puntes, Víctor|||0000-0001-8996-9499
  • Italiani, Paola|||0000-0001-9830-2733
  • De Luca, Anna Chiara|||0000-0002-3696-8465
The interaction between engineered nanoparticles and the bacterial lipopolysaccharide, or endotoxin, is an event that warrants attention. Endotoxin is one of the most potent stimulators of inflammation and immune reactions in human beings, and is a very common contaminant in research labs. In nanotoxicology and nanomedicine, the presence of endotoxin on the nanoparticle surface affects their biological properties leading to misinterpretation of results. This review discusses the importance of detecting the endotoxin contamination on nanoparticles, focusing on the current method of endotoxin detection and their suitability for nanoparticulate materials. Conversely, the capacity of nanoparticles to bind endotoxin can be enhanced by functionalization with endotoxin-capturing molecules, opening the way to the development of novel endotoxin detection assays.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Innate memory reprogramming by gold nanoparticles depends on the microbial agents that induce memory

  • Swartzwelter, Benjamin J.
  • Michelini, Sara|||0000-0001-9470-3337
  • Frauenlob, Tobias
  • Barbero, Francesco|||0000-0001-8704-0651
  • Verde, Alessandro
  • De Luca, Anna Chiara|||0000-0002-3696-8465
  • Puntes, Víctor|||0000-0001-8996-9499
  • Duschl, Albert|||0000-0002-7034-9860
  • Horejs-Hoeck, Jutta|||0000-0002-0984-204X
  • Italiani, Paola|||0000-0001-9830-2733
  • Boraschi, Diana|||0000-0002-3953-4056
Innate immune memory, the ability of innate cells to react in a more protective way to secondary challenges, is induced by exposure to infectious and other exogeous and endogenous agents. Engineered nanoparticles are particulate exogenous agents that, as such, could trigger an inflammatory reaction in monocytes and macrophages and could therefore be also able to induce innate memory. Here, we have evaluated the capacity of engineered gold nanoparticles (AuNPs) to induce a memory response or to modulate the memory responses induced by microbial agents. Microbial agents used were in soluble vs. particulate form (MDP and the gram-positive bacteria Staphylococcus aureus; β-glucan and the β-glucan-producing fungi C. albicans), and as whole microrganisms that were either killed (S. aureus, C. albicans) or viable (the gram-negative bacteria Helicobacter pylori). The memory response was assessed in vitro, by exposing human primary monocytes from 2-7 individual donors to microbial agents with or without AuNPs (primary response), then resting them for 6 days to allow return to baseline, and eventually challenging them with LPS (secondary memory response). Primary and memory responses were tested as production of the innate/inflammatory cytokine TNFα and other inflammatory and anti-inflammatory factors. While inactive on the response induced by soluble microbial stimuli (muramyl dipeptide -MDP-, β-glucan), AuNPs partially reduced the primary response induced by whole microorganisms. AuNPs were also unable to directly induce a memory response but could modulate stimulus-induced memory in a circumscribed fashion, limited to some agents and some cytokines. Thus, the MDP-induced tolerance in terms of TNFα production was further exacerbated by co-priming with AuNPs, resulting in a less inflammatory memory response. Conversely, the H. pylori-induced tolerance was downregulated by AuNPs only relative to the anti-inflammatory cytokine IL-10, which would lead to an overall more inflammatory memory response. These effects of AuNPs may depend on a differential interaction/association between the reactive particle surfaces and the microbial components and agents, which may lead to a change in the exposure profiles. As a general observation, however, the donor-to-donor variability in memory response profiles and reactivity to AuNPs was substantial, suggesting that innate memory depends on the individual history of exposures.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Induction of Innate Memory in Human Monocytes Exposed to Mixtures of Bacterial Agents and Nanoparticles

  • Della Camera, Giacomo
  • Liu, Tinghao
  • Yang, Wenjie
  • Li, Yang|||0000-0001-7242-4687
  • Puntes, Víctor|||0000-0001-8996-9499
  • Gioria, Sabrina|||0000-0001-7150-9523
  • Italiani, Paola|||0000-0001-9830-2733
  • Boraschi, Diana|||0000-0002-3953-4056
We assessed whether concomitant exposure of human monocytes to bacterial agents and different engineered nanoparticles can affect the induction of protective innate memory, an immune mechanism that affords better resistance to diverse threatening challenges. Monocytes were exposed in vitro to nanoparticles of different chemical nature, shape and size either alone or admixed with LPS, and cell activation was assessed in terms of production of inflammatory (TNFα, IL-6) and anti-inflammatory cytokines (IL-10, IL-1Ra). After return to baseline conditions, cells were re-challenged with LPS and their secondary "memory" response measured. Results show that nanoparticles alone are essentially unable to generate memory, while LPS induced a tolerance memory response (less inflammatory cytokines, equal or increased anti-inflammatory cytokines). LPS-induced tolerance was not significantly affected by the presence of nanoparticles during the memory generation phase, although with substantial donor-to-donor variability. This suggests that, despite the overall lack of significant effects on LPS-induced innate memory, nanoparticles may have donor-specific effects. Thus, future nanosafety assessment and nanotherapeutic strategies will need a personalized approach in order to ensure both the safety and efficacy of nano medical compounds for individual patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recovering What Matters, High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates

  • Casonato Melo, Cristiane|||0000-0003-1013-585X
  • Fux, Alexandra C.|||0000-0001-8745-829X
  • Himly, Martin|||0000-0001-5416-085X
  • Bastús, Neus G|||0000-0002-3144-7986
  • Schlahsa, Laura
  • Siewert, Christiane
  • Puntes, Víctor|||0000-0001-8996-9499
  • Duschl, Albert|||0000-0002-7034-9860
  • Gessner, Isabel|||0000-0001-9674-161X
  • Fauerbach, Jonathan A.|||0000-0002-1540-0352
Endotoxins or lipopolysaccharides (LPS), found in the outer membrane of Gram-negative bacterial cell walls, can stimulate the human innate immune system, leading to life-threatening symptoms. Therefore, regulatory limits for endotoxin content apply to injectable pharmaceuticals, and excess LPS must be removed before commercialization. The majority of available endotoxin removal systems are based on the non-specific adsorption of LPS to charged and/or hydrophobic surfaces. Albeit effective to remove endotoxins, the lack of specificity can result in the unwanted loss of essential proteins from the pharmaceutical formulation. In this work, we developed microparticles conjugated to anti-Lipid A antibodies for selective endotoxin removal. Anti-Lipid A particles were characterized using flow cytometry and microscopy techniques. These particles exhibited a depletion capacity > 6 ×10 3 endotoxin units/mg particles from water, as determined with two independent methods (Limulus Amebocyte Lysate test and nanoparticle tracking analysis). Additionally, we compared these particles with a non-specific endotoxin removal system in a series of formulations of increasing complexity: bovine serum albumin in water < insulin in buffer < birch pollen extracts. We demonstrated that the specific anti-Lipid A particles show a higher protein recovery without compromising their endotoxin removal capacity. Consequently, we believe that the specificity layer integrated by the anti-Lipid A antibody could be advantageous to enhance product yield.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates

  • Casonato Melo, Cristiane
  • Fux, Alexandra
  • Himly, Martin
  • Schlahsa, Laura
  • Siewert, Christiane
  • Franco Puntes, Victor
  • G. Bastús, Neus
Bioconjugation; Polystyrene particles; Supramolecular structures, Bioconjugación; Partículas de poliestireno; Estructuras supramoleculares, Bioconjugació; Partícules de poliestirè; Estructures supramoleculars, Endotoxins or lipopolysaccharides (LPS), found in the outer membrane of Gram-negative bacterial cell walls, can stimulate the human innate immune system, leading to life-threatening symptoms. Therefore, regulatory limits for endotoxin content apply to injectable pharmaceuticals, and excess LPS must be removed before commercialization. The majority of available endotoxin removal systems are based on the non-specific adsorption of LPS to charged and/or hydrophobic surfaces. Albeit effective to remove endotoxins, the lack of specificity can result in the unwanted loss of essential proteins from the pharmaceutical formulation. In this work, we developed microparticles conjugated to anti-Lipid A antibodies for selective endotoxin removal. Anti-Lipid A particles were characterized using flow cytometry and microscopy techniques. These particles exhibited a depletion capacity > 6 ×103 endotoxin units/mg particles from water, as determined with two independent methods (Limulus Amebocyte Lysate test and nanoparticle tracking analysis). Additionally, we compared these particles with a non-specific endotoxin removal system in a series of formulations of increasing complexity: bovine serum albumin in water < insulin in buffer < birch pollen extracts. We demonstrated that the specific anti-Lipid A particles show a higher protein recovery without compromising their endotoxin removal capacity. Consequently, we believe that the specificity layer integrated by the anti-Lipid A antibody could be advantageous to enhance product yield., The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 812661, H2020-MSCA-ITN-2018-812661 (ENDONANO).